State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 264 actively recruiting studies with Arizona sites out of 264 registered in total. The busiest research areas in Arizona are Breast Cancer, Multiple Myeloma, Hematopoietic and Lymphatic System Neoplasm. Leading sponsors running trials in the state include Mayo Clinic, National Cancer Institute (NCI), University of Arizona. By stage, Arizona trials break down as Phase 1 (43), Phase 2 (72), Phase 3 (84), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Breast Cancer (11)Multiple Myeloma (5)Hematopoietic and Lymphatic System Neoplasm (4)Acute Myeloid Leukemia (4)Endometrial Cancer (4)Geographic Atrophy (3)Anatomic Stage II Breast Cancer AJCC v8 (3)Alzheimer Disease (3)Prostate Cancer (3)Malignant Solid Neoplasm (3)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (3)Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (3)
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 264 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 264. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Hematopoietic and Lymphatic System Neoplasm, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT07384975 Phase 2
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States
Sponsor
Navigator Medicines, Inc.
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT07675681 N/A
Recruiting
REmote Virtual Inspiration: Vitality and Energy
Condition
Implementation Science
Enrollment
280 pts
Location
United States
Sponsor
Arizona State University
NCT07335562 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleu...
Condition
Systemic Sclerosis
Enrollment
92 pts
Location
United States, Belgium, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
NCT06619990 Phase 1, Phase 2
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Coliti...
Condition
Ulcerative Colitis (UC)
Enrollment
270 pts
Location
United States, Australia, Bulgaria
Sponsor
Xencor, Inc.
NCT07409103 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat ...
Condition
Active Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, South Africa
Sponsor
Elevara Medicines Limited
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Condition
Advanced Solid Tumor
Enrollment
140 pts
Location
United States, United Kingdom
Sponsor
Nuvectis Pharma, Inc.
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT07089927 N/A
Recruiting
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes ...
Condition
Malignant Solid Neoplasm
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
NCT04588922 Phase 1, Phase 2
Recruiting
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Pa...
Condition
Hematologic Malignancies
Enrollment
160 pts
Location
United States, China
Sponsor
Sellas Life Sciences Group
NCT06455449 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Su...
Condition
Polymyositis, Dermatomyositis
Enrollment
240 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT06332040 Phase 4
Recruiting
Gentamicin Bladder Instillation on CAUTI
Condition
Catheter Infection
Enrollment
400 pts
Location
United States
Sponsor
St. Joseph's Hospital and Medi
NCT05835310 Phase 3
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus ...
Condition
Systemic Lupus Erythematosus
Enrollment
100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT05530343 N/A
Recruiting
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients Wi...
Condition
Barrett Esophagus
Enrollment
2,298 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06023589 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Plac...
Condition
Asthma
Enrollment
231 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT05184335 Phase 3
Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Condition
Schizophrenia
Enrollment
690 pts
Location
United States
Sponsor
Reviva Pharmaceuticals
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
NCT06960213 Phase 3
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Condition
Hereditary Angioedema
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
ADARx Pharmaceuticals, Inc.
NCT02958462 N/A
Recruiting
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Condition
Myeloid Malignancy
Enrollment
2,000 pts
Location
United States
Sponsor
Mayo Clinic
NCT06279013 N/A
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and P...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
NCT06712810 Phase 1
Recruiting
Q702 for the Treatment of Patients With Hematologic Malignancies
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
46 pts
Location
United States
Sponsor
Mayo Clinic
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT07195591 Phase 3
Recruiting
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard o...
Condition
Glioblastoma
Enrollment
766 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology